PPARα-MO-1 rene D5 It is given by intravenous

It is given by intravenous infusion once every two weeks for three to six months

Binding to cell membranes and plasma proteins may be involved in the compound's cytotoxic effects

6-O-alpha-D-Maltosyl-beta-cyclodextrin

Valrubicin competes with the tumor promoter for the PKC binding site and prevents the latter from both interacting with the phospholipid and binding to PKC

CAS Number: 63-45-6

PPARα-MO-1 rene D5 It is given by intravenousPPAR MO 1 is a potent PPAR modulator extracted from patent WO 2004 110982A1, formula I. Product information CAS Number: 810677 36 2 Molecular Weight: 455. 59 Formula: C27H37NO5 Chemical Name: 2 ethoxy 3 (4 {[hexyl(2 phenylethyl)carbamoyl]methoxy}phenyl)propanoic acid Smiles: CCCCCCN(CCC1C=CC=CC=1)C(=O)COC1C=CC(CC(OCC)C(O)=O)=CC=1 InChiKey: VFYAWARECOZRBD UHFFFAOYSA N InChi: InChI=1S C27H37NO5 c1 3 5 6 10 18 28(19 17 22 11 8 7 9 12 22)26(29)21 33 24 15